SCYX

SCYX

USD

SCYNEXIS Inc. Common Stock

$0.640-0.010 (-1.538%)

Prix en Temps Réel

Healthcare
Drug Manufacturers - Specialty & Generic
États-Unis

Graphique des Prix

Loading Chart...

Métriques Clés

Métriques de Marché
Fondamentaux de l'Entreprise
Statistiques de Trading

Métriques de Marché

Ouverture

$0.650

Haut

$0.650

Bas

$0.620

Volume

0.34M

Fondamentaux de l'Entreprise

Capitalisation Boursière

27.0M

Industrie

Drug Manufacturers - Specialty & Generic

Pays

United States

Statistiques de Trading

Volume Moyen

0.43M

Bourse

NGM

Devise

USD

Intervalle sur 52 Semaines

Bas $0.62Actuel $0.640Haut $1.49

Actualités Connexes

Analyst Upgrades

Guggenheim Maintains Buy on SCYNEXIS, Lowers Price Target to $3

Guggenheim analyst Vamil Divan maintains SCYNEXIS with a Buy and lowers the price target from $4 to $3.

Voir plus
Guggenheim Maintains Buy on SCYNEXIS, Lowers Price Target to $3
GlobeNewswire

SCYNEXIS and GSK Resolve Their Disagreement Related to the Restart of the Phase 3 MARIO Study

SCYNEXIS to receive a $22 million payment as part of the resolution related to the restart of the Phase 3 MARIO study on invasive candidiasisScynexis will promptly wind-down and terminate the MARIO studyThe payment from

Voir plus
SCYNEXIS and GSK Resolve Their Disagreement Related to the Restart of the Phase 3 MARIO Study